COMPARISON OF CABERGOLINE VERSUS RALOXIFENE ADD-ON THERAPY TO LONG-ACTING SOMATOSTATIN ANALOGUE IN PATIENTS WITH INADEQUATELY CONTROLLED ACROMEGALY: A RANDOMIZED OPEN LABEL CLINICAL TRIAL

Mehrnaz Imani; Mohammad Ebrahim Khamseh; Poopak Asadi; Mohammad Ghorbani; Hamideh Akbari; Fariba Alaei-Shahmiri; Maryam Honardoost; Mahmoud Reza Kaynama; Mojtaba Malek

doi:10.4158/ep-2017-0195

COMPARISON OF CABERGOLINE VERSUS RALOXIFENE ADD-ON THERAPY TO LONG-ACTING SOMATOSTATIN ANALOGUE IN PATIENTS WITH INADEQUATELY CONTROLLED ACROMEGALY: A RANDOMIZED OPEN LABEL CLINICAL TRIAL

Endocrine Practice ◽

10.4158/ep-2017-0195 ◽

2018 ◽

Vol 24 (6) ◽

pp. 542-547 ◽

Cited By ~ 3

Author(s):

Mehrnaz Imani ◽

Mohammad Ebrahim Khamseh ◽

Poopak Asadi ◽

Mohammad Ghorbani ◽

Hamideh Akbari ◽

...

Keyword(s):

Clinical Trial ◽

Somatostatin Analogue ◽

Open Label ◽

Long Acting

Download Full-text

Erratum: Relapse Prevention in Schizophrenia and Schizoaffective Disorder with Risperidone Long-Acting Injectable vs Quetiapine: Results of a Long-Term, Open-Label, Randomized Clinical Trial

Neuropsychopharmacology ◽

10.1038/npp.2010.206 ◽

2010 ◽

Vol 36 (2) ◽

pp. 548-548

Author(s):

Wolfgang Gaebel ◽

Andreas Schreiner ◽

Paul Bergmans ◽

Rosario de Arce ◽

Frédéric Rouillon ◽

...

Keyword(s):

Clinical Trial ◽

Randomized Clinical Trial ◽

Schizoaffective Disorder ◽

Relapse Prevention ◽

Open Label ◽

Long Acting

Download Full-text

Relapse Prevention in Schizophrenia and Schizoaffective Disorder with Risperidone Long-Acting Injectable vs Quetiapine: Results of a Long-Term, Open-Label, Randomized Clinical Trial

Neuropsychopharmacology ◽

10.1038/npp.2010.111 ◽

2010 ◽

Vol 35 (12) ◽

pp. 2367-2377 ◽

Cited By ~ 64

Author(s):

Wolfgang Gaebel ◽

Andreas Schreiner ◽

Paul Bergmans ◽

Rosario de Arce ◽

Frédéric Rouillon ◽

...

Keyword(s):

Clinical Trial ◽

Randomized Clinical Trial ◽

Schizoaffective Disorder ◽

Relapse Prevention ◽

Open Label ◽

Long Acting

Download Full-text

Efficacy and Safety of a Long-Acting Multilayer-Release Methylphenidate Formulation (PRC-063) in the Treatment of Adolescent Attention-Deficit/Hyperactivity Disorder: A Randomized, Double-Blind Clinical Trial with a 6-Month Open-Label Extension

Journal of Child and Adolescent Psychopharmacology ◽

10.1089/cap.2021.0034 ◽

2021 ◽

Author(s):

Margaret D. Weiss ◽

Andrew J. Cutler ◽

Scott H. Kollins ◽

Graeme A.E. Donnelly

Keyword(s):

Clinical Trial ◽

Attention Deficit Hyperactivity Disorder ◽

Attention Deficit ◽

Efficacy And Safety ◽

Open Label ◽

Double Blind ◽

Hyperactivity Disorder ◽

Double Blind Clinical Trial ◽

Open Label Extension ◽

Long Acting

Download Full-text

Open-label (OL) extension trial of the safety and tolerability of OROS® methylphenidate in adults with ADHD – the long-acting methylphenidate in adult ADHD (LAMDA) trial

Pharmacopsychiatry ◽

10.1055/s-2007-991879 ◽

2007 ◽

Vol 40 (05) ◽

Author(s):

A Philipsen ◽

GE Trott ◽

M Roesler ◽

M Gerwe ◽

E Lee ◽

...

Keyword(s):

Adult Adhd ◽

Open Label ◽

Long Acting ◽

Extension Trial

Download Full-text

Biochemical control was sustained with long-acting pasireotide in patients with uncontrolled acromegaly over continued treatment with first-generation somatostatin analogues (SSAs): Results from the extension of phase 3b, open-label study

Endocrine Abstracts ◽

10.1530/endoabs.63.gp57 ◽

2019 ◽

Author(s):

Monica Gadelha ◽

Annamaria Colao ◽

Marie Bex ◽

Rishav Mukherjee ◽

Catherine Bourad ◽

...

Keyword(s):

First Generation ◽

Somatostatin Analogues ◽

Biochemical Control ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

Long Acting

Download Full-text

1068-P: A Prospective, Multicenter, Randomized, Open-Label, Parallel-Group Clinical Trial Comparing the Safety Profile of a Needle-Free Insulin Injector with Conventional Insulin Pen Injections in Chinese Patients with Type 2 Diabetes Mellitus

Diabetes ◽

10.2337/db19-1068-p ◽

2019 ◽

Vol 68 (Supplement 1) ◽

pp. 1068-P

Author(s):

LIMING CHEN ◽

LINONG JI ◽

YANGANG WANG ◽

ZHONGSHU MA ◽

XINGWU RAN ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Clinical Trial ◽

Type 2 Diabetes Mellitus ◽

Safety Profile ◽

Chinese Patients ◽

Open Label ◽

Parallel Group ◽

Free Insulin

Download Full-text

Faculty Opinions recommendation of Long-Acting Injectable Risperidone for Relapse Prevention and Control of Breakthrough Symptoms After a Recent First Episode of Schizophrenia. A Randomized Clinical Trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.725585522.793511377 ◽

2015 ◽

Author(s):

Steven Potkin ◽

Adrian Preda

Keyword(s):

Clinical Trial ◽

Randomized Clinical Trial ◽

Relapse Prevention ◽

Prevention And Control ◽

First Episode ◽

Long Acting ◽

And Control ◽

First Episode Of Schizophrenia

Download Full-text

Faculty Opinions recommendation of Prophylactic antibiotics after acute stroke for reducing pneumonia in patients with dysphagia (STROKE-INF): a prospective, cluster-randomised, open-label, masked endpoint, controlled clinical trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.725773098.793512987 ◽

2016 ◽

Author(s):

David McDonagh

Keyword(s):

Clinical Trial ◽

Acute Stroke ◽

Prophylactic Antibiotics ◽

Controlled Clinical Trial ◽

Open Label ◽

Cluster Randomised

Download Full-text

Faculty Opinions recommendation of Long-acting intramuscular cabotegravir and rilpivirine in adults with HIV-1 infection (LATTE-2): 96-week results of a randomised, open-label, phase 2b, non-inferiority trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.727847958.793541123 ◽

2018 ◽

Author(s):

Anthony Harries ◽

Kudakwashe C Takarinda

Keyword(s):

Open Label ◽

Open Label Phase ◽

Long Acting ◽

Hiv 1

Download Full-text

Faculty Opinions recommendation of Intravesical nadofaragene firadenovec gene therapy for BCG-unresponsive non-muscle-invasive bladder cancer: a single-arm, open-label, repeat-dose clinical trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.739122585.793581022 ◽

2020 ◽

Author(s):

Otto Hemminki

Keyword(s):

Clinical Trial ◽

Gene Therapy ◽

Bladder Cancer ◽

Invasive Bladder Cancer ◽

Repeat Dose ◽

Open Label ◽

Muscle Invasive Bladder Cancer ◽

Muscle Invasive

Download Full-text